Françoise Schillinger

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

Francine Garnache‐Ottou, Chrystelle Vidal, Sabeha Biichlé et al. · Blood Advances · 2019 · 121 citations · Full text

Medicine, Hematology, Oncology +17

Additional erythrocytic and reticulocytic parameters helpful for diagnosis of hereditary spherocytosis: results of a multicentre study

François Mullier, Élodie Lainey, Odile Fenneteau et al. · Annals of Hematology · 2010 · 76 citations

Medicine, Hematology, Pathology +11

CD304 is preferentially expressed on a subset of B‐lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry

Françoise Solly, Fanny Angelot, Richard Garand et al. · Cytometry Part A · 2011 · 41 citations · Full text

Medicine, Hematology, Oncology +17

Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT‐X) determined by the Sysmex XE‐2100^TM

G Roux, Amalia Vlad, Virginie Éclache et al. · International Journal of Laboratory Hematology · 2010 · 39 citations

Medicine, Hematology, Pathology +17

A new approach for diagnosing chronic myelomonocytic leukemia using structural parameters of Sysmex XN^TM analyzers in routine laboratory practice

Françoise Schillinger, Élise Sourdeau, Marouane Boubaya et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 2018 · 25 citations · Full text

Medicine, Hematology, Pathology +17